Session 2: Von Willebrand factor and von Willebrand Disease in ageing: mechanisms, evolving phenotypes, and clinical implications

Speakers: Flora Peyvandi, Cathy Verbraeken

Flora Peyvandi,

Prof Peyvandi is a Professor of Internal Medicine, University of Milan and director of the Angelo Bianchi Bonomi Hemophilia and Thrombosis Center. She is head of the Department of Rare Disorders at the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico with 15 ERNs. Since many years, Prof. Peyvandi has been participating in clinical, educational and research activities of different European and International scientific societies and patients' organizations. She is currently the President of the International Society of Thrombosis and Haemostasis (ISTH). She serves as advisor on the European Agency of Medicine (EMA) and on the Technical Health Committee of the Italian Ministry of Health. Her H-index of 78 (Scopus), with a large experience in research development in the field of haemostasis and thrombosis.

Cathy Verbraeken,

Cathy Verbraeken is a member of the EHC von Willebrand Committee and is also the chair of the von Willebrand Committee of the Dutch NMO. Cathy and her two daughters have von Willebrand disease, types 1 and 2N. She is giving her best to advocate for better care, more treatment options, and increased awareness of von Willebrand disease.